$FT

Franklin Universal Trust (NYSE:FT) Short Interest Up 117.2% in March

Franklin Universal Trust (NYSE:FT) experienced a significant 117.2% increase in short interest in March, reaching 17,023 shares. This rise translates to a days-to-cover ratio of 0.4 days, indicating a very quick potential for short positions to be covered. The company also declared a monthly dividend of $0.0425 per share, offering an annualized yield of 6.4%, while its stock traded at $7.91 with below-average volume.

Original reporting
MarketBeat · MarketBeat
Published Mar 27, 2026, 8:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 27, 2026, 9:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Franklin Universal Trust (NYSE:FT) Short Interest Up 117.2% in March — source image
Decision brief

The 30-second read

$FTBearishLow
01

Why it matters

The surge in short interest may pressure the stock price in the short term, but limited liquidity and low volume suggest cautious trading. The dividend yield remains a key factor for income investors.

02

Market read

The news has limited broader market impact but is relevant for traders and investors holding or considering FT positions.

03

What to watch

The low days-to-cover ratio suggests limited risk of a significant short squeeze; also, dividend yield remains attractive for income-focused investors, which could support the stock price.

Timing: short-term

Background

Franklin Universal Trust (NYSE:FT) is a closed-end fund investing in a diversified portfolio of income-producing securities. The recent rise in short interest indicates increased bearish bets, possibly due to sector concerns or company-specific factors.

Company-level read

Ticker impact

$FTBearishMedium confidence
Context

The news reports a 117.2% increase in short interest for Franklin Universal Trust (NYSE:FT) in March, reaching 17,023 shares, with a very low days-to-cover ratio of 0.4 days. The stock traded at $7.91, with below-average volume, and a somewhat-bearish sentiment score of -0.210084.

Expected impact

Potential short-term downward pressure or sideways movement; limited upside unless positive news materializes.

Evidence & confidence

The sharp increase in short interest indicates increased bearish sentiment, but the low volume and modest stock price suggest limited immediate impact. The bearish sentiment score supports cautious outlook.

Market effects

The rise in short interest may reflect sector-wide concerns about similar financial trusts or REITs, but specific sector impact is limited without broader industry data.

Minimal regional impact; the news pertains to a US-listed trust.

Limited

Counterpoint

The increase in short interest could be a contrarian indicator signaling a potential short squeeze if the stock's fundamentals improve or if short sellers cover positions rapidly.

Key entities

  • Franklin Universal Trust

    A closed-end fund focusing on income-generating securities.

Related articles

$FSMMed

Fortuna bets $71M on Latin America gold growth

Fortuna Mining plans to invest $71 million in Argentina and Peru in 2026 to raise gold output and expand operations. It will spend $41 million at the Lindero gold mine in Argentina, targeting 92,000 to 102,000 oz in 2026. Fortuna also plans $29.9 million at Peru’s Caylloma mine, with 28% expansion progress and 2026 guidance of 29,000 to 33,000 GEO.

$FTMedAI 8/10

Fortune – Tlicho Joint Venture to Receive up to $50 Million From Government of Canada First and Last Mile Fund

Fortune Minerals’ joint venture with the Tłıchǫ Government received conditional approval for up to C$50 million from Canada’s First and Last Mile Fund to reimburse 75% of costs for the 51-km NICO project access road in the Northwest Territories. The road will connect the NICO cobalt-gold-bismuth-copper mine to the highway near Whatì, supporting mine construction and operations.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

$BKRMed

Baker Hughes (BKR) Lands Multi-Year Contract with Pakistan’s OGDC

Baker Hughes (BKR) secured a multi-year contract with Pakistan's OGDC to enhance production from mature oil and gas fields. The deal involves assessing 120 wells and providing tailored redevelopment plans. Baker Hughes aims to use AI and other technologies to improve flow assurance and restore production. The contract aligns with Baker Hughes' strategy to diversify revenue and reduce reliance on short-term drilling cycles, as evidenced by a 49% YoY increase in orders to $10.5 billion in Q2. Howe